Bio Medica Laboratories IPO Live GMP Today
As of 28 May 2026, 08:35 pm IST, Bio Medica Laboratories SME IPO is quoting a grey market premium of ₹-6 (-4.3% over the issue price), implying a listing around ₹133 per share.
| Status | Listed |
| Type | SME |
| Open Date | May 21, 2026 |
| Close Date | May 25, 2026 |
| Listing Date | May 29, 2026 |
| Lot Size | 2000 shares |
| Issue Size | ₹52.43 Cr |
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| May 28, 2026 08:35 pm | -6 | ▼ 9 | -4.3% | ₹133 |
| May 28, 2026 07:54 pm | +3 | ▲ 9 | +2.2% | ₹142 |
| May 27, 2026 01:35 pm | -6 | ▼ 8 | -4.3% | ₹133 |
| May 22, 2026 02:52 pm | +2 | ▼ 2 | +1.4% | ₹141 |
| May 21, 2026 05:27 pm | +4 | ▲ 4 | +2.9% | ₹143 |
| May 18, 2026 07:40 am | +0 | — | — | ₹139 |
Bio Medica Laboratories IPO GMP — Detailed Analysis
What Bio Medica Laboratories GMP Tells Us Today
The current Grey Market Premium for Bio Medica Laboratories IPO is Rs -6 (-4.3% over the issue price). Based on this GMP, the implied listing price hovers around Rs 133 per share. Across the 6 GMP records captured for this issue, the trend has been declining by Rs 6 — a useful directional signal for gauging investor sentiment as the listing date approaches.
Bio Medica Laboratories IPO is expected to list on May 29, 2026.
Bio Medica Laboratories IPO GMP — FAQs
New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?